同仁堂国药发布年度业绩 股东应占溢利5亿港元 同比减少7.4%

智通财经
28 Mar

智通财经APP讯,同仁堂国药(03613)发布截至2024年12月31日止年度业绩,收入16.12亿港元,同比增加5.7%;股东应占溢利5亿港元,同比减少7.4%;每股基本盈利0.6港元,拟派发末期股息每股0.35港元。公告称,收入上升乃主要来自中国香港市场及中国内地市场收入增长。尽管中国香港零售市道持续疲弱,中国香港市场收入同比增长16.9%,主要归因集团于本年下半年在中国香港加强产品营销推广...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10